# Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

> **NCT00213486** · PHASE2 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 43 (actual)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **DRUG:** irinotecan

## Key facts

- **NCT ID:** NCT00213486
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01-15
- **Primary completion:** 2006-06-23
- **Final completion:** 2006-06-23
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213486, "Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00213486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*